Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Špela Kos

PhD Špela Kos
no.: 36366 source: ARIS

researcher – not employed in research organisation
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
143.99
A''
64.72
A'
101.18
A1/2
121.77
CI10
419
CImax
163
h10
10
A1
0.57
A3
0.08
Data for the last 5 years (citations for the last 10 years) on April 24, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 24  484  372  15.5 
Scopus 21  521  414  19.71 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   2021 - 2022  PhD Anže Smole  2,499 
2. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2022  PhD Gregor Serša  6,770 
3. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2022  PhD Boštjan Markelc  3,338 
4. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2020 - 2022  PhD Mateja Erdani Kreft  5,131 
5. J2-9225  Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields   2018 - 2021  PhD Damijan Miklavčič  2,900 
6. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018  PhD Gregor Serša  3,496 
7. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2018  PhD Maja Čemažar  3,542 
8. N3-0059  Plasma-assisted wound treatment and topical introduction of molecules   2017 - 2018  PhD Uroš Cvelbar  3,038 
9. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,257 
10. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,092 
11. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,738 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0428  Comparative oncology for tackling rare cancers   2022  PhD Ario de Marco  903 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2018  PhD Gregor Serša  3,264 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2013 - 2014  PhD Gregor Serša  4,018 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite